Star Health breakout clears ₹600 resistance. Now the hard part.

Star Health and Allied Insurance hit a fresh 52-week high in June, clearing a multi-year resistance band that had capped the stock since the pandemic-era selloff. The insurer closed at ₹625.40, up 8% for the month, after weeks of consolidation near the ₹600 level.

The breakout came on above-average volume. Daily traded shares in the final week of June ran roughly 1.5 times the 20-day average. The resistance zone between ₹580 and ₹600 had rejected price advances in March and April. The June push cleared that zone on a closing basis.

For a trader looking at this setup, the simple read is a buy on the breakout with the former resistance as a new support floor. The better read is more cautious. The stock tested the ₹580-600 zone twice before and failed to hold gains above it. The third attempt succeeded on higher volume, which improves the odds. The sector backdrop is mixed. Private health insurers have been under margin pressure from rising claim ratios. Star Health's combined ratio – a measure of underwriting profitability – has trended above 100% for three straight quarters.

The breakout holds if the stock stays above ₹600 on a weekly closing basis and the relative strength index stays below 70. A weekly close below ₹600 would turn the breakout into a false signal and put the ₹540 support back in play. A sharp reversal below the breakout zone – a daily close under ₹580 – would invalidate the move. So would a volume collapse. If the stock drifts back into the ₹580-600 range on declining volume, that is a sign the breakout lacked conviction.

The next event for the sector is the July quarterly earnings. Star Health's claim ratios and premium growth will be in focus. V. Jagannathan, the company's chairman, told analysts in May that the firm expects the combined ratio to improve in the second half of the fiscal year. If the numbers support that view, the technical setup has room to run. If they do not, the breakout will look like a head fake.